Literature DB >> 1432133

Extracranial complications of severe head injury.

J Piek1, R M Chesnut, L F Marshall, M van Berkum-Clark, M R Klauber, B A Blunt, H M Eisenberg, J A Jane, A Marmarou, M A Foulkes.   

Abstract

In order to define the role of intracranial and extracranial complications in determining outcome from severe head injury, 734 patients from the Traumatic Coma Data Bank were analyzed. Nine classes of intracranial and 13 classes of extracranial complications occurring within the first 14 days after admission were analyzed, while controlling for age, admission Glasgow Coma Scale motor score, early hypoxia or hypotension, and severe extracranial trauma. Outcome for survivors was based on the last recorded Glasgow Outcome Scale score, obtained a median of 521 days after injury. Intracranial complications did not significantly alter outcome for the study group. Of the extracranial complications, pulmonary, cardiovascular, coagulation, and electrolyte disorders occurred most frequently at 2 to 4 days. Infections developed later, peaking at 5 to 11 days. Gastrointestinal, renal, and hepatic complications followed no specific time course. Electrolyte abnormalities were the most frequent occurrence (59% of patients) but did not alter outcome. Pulmonary infections (41%), shock (29%, systemic blood pressure < or = 90 mm Hg for 30 minutes or more), coagulopathy (19%), and septicemia (10%) were significant independent predictors of an unfavorable outcome. Backward-elimination, stepwise logistic regression modeling indicated that the estimated reduction of unfavorable outcome was 2.9% for the elimination of pneumonia, 3.1% for coagulation disturbances, 1.5% for septicemia, and 9.3% for shock. These data suggest that extracranial complications are highly influential in determining the outcome from severe head injury and that significant improvements in outcome in a sizeable proportion of patients could be accomplished by improving the ability to prevent or reverse pneumonia, hypotension, coagulopathy, and sepsis.

Entities:  

Mesh:

Year:  1992        PMID: 1432133     DOI: 10.3171/jns.1992.77.6.0901

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  57 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Brain-lung crosstalk: Implications for neurocritical care patients.

Authors:  Ségolène Mrozek; Jean-Michel Constantin; Thomas Geeraerts
Journal:  World J Crit Care Med       Date:  2015-08-04

3.  Alterations of natural killer cells in traumatic brain injury.

Authors:  Xiao-Dong Kong; Sheng Bai; Xin Chen; Hui-Jie Wei; Wei-Na Jin; Min-Shu Li; Yaping Yan; Fu-Dong Shi
Journal:  Neurosci Bull       Date:  2014-12-02       Impact factor: 5.203

4.  Improving Understanding and Outcomes of Traumatic Brain Injury Using Bidirectional Translational Research.

Authors:  William M Armstead; Monica S Vavilala
Journal:  J Neurotrauma       Date:  2019-06-13       Impact factor: 5.269

5.  Acute Traumatic Coagulopathy Accompanying Isolated Traumatic Brain Injury is Associated with Worse Long-Term Functional and Cognitive Outcomes.

Authors:  Peter A Abdelmalik; David W Boorman; Joseph Tracy; Jack Jallo; Fred Rincon
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

6.  Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial.

Authors:  Hosseinali Khalili; Rebecka Ahl; Shahram Paydar; Gabriel Sjolin; Yang Cao; Hossein Abdolrahimzadeh Fard; Amin Niakan; Kamil Hanna; Bellal Joseph; Shahin Mohseni
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

Review 7.  Coagulopathy associated with traumatic brain injury.

Authors:  Monisha A Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

8.  Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy.

Authors:  Patrick K Davis; Harsha Musunuru; Mark Walsh; Robert Cassady; Robert Yount; Andrew Losiniecki; Ernest E Moore; Max V Wohlauer; Janet Howard; Victoria A Ploplis; Francis J Castellino; Scott G Thomas
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

9.  Different functions of HIPK2 and CtBP2 in traumatic brain injury.

Authors:  Feihui Zou; Jian Xu; Hongran Fu; Jianhua Cao; Hui Mao; Mingjie Gong; Gang Cui; Yang Zhang; Wei Shi; Jian Chen
Journal:  J Mol Neurosci       Date:  2012-10-18       Impact factor: 3.444

10.  The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury.

Authors:  Umberto Maggiore; Edoardo Picetti; Elio Antonucci; Elisabetta Parenti; Giuseppe Regolisti; Mario Mergoni; Antonella Vezzani; Aderville Cabassi; Enrico Fiaccadori
Journal:  Crit Care       Date:  2009-07-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.